Sugeno and colleagues reported that α‐synuclein in the nucleus might activate H3K9 via the EHMT2 protein, and such an epigenetic effect could affect a neural cell adhesion molecule and a synaptosomal‐associated protein, leading to the synaptic dysfunction occurring in PD.47 Here, CHL1 is linked to Parkinson disease.